Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Chih Liu

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Journal of Chemical Information and Modeling|February 26, 2016
Identification of Novel Disruptor of Telomeric Silencing 1-like (DOT1L) Inhibitors through Structure-Based Virtual Screening and Biological AssaysShijie Chen, Linjuan Li, Yantao Chen, et al.
Chemmedchem|November 14, 2014
From ergolines to indoles: improved inhibitors of the human H3 receptor for the treatment of narcolepsyYves P Auberson, Thomas Troxler, Xuechun Zhang, et al.
Journal of Medicinal Chemistry|October 22, 2014
Identifying novel selective non-nucleoside DNA methyltransferase 1 inhibitors through docking-based virtual screeningShijie Chen, Yulan Wang, Wen Zhou, et al.
Journal of Medicinal Chemistry|October 12, 2017
Development of Potent Type I Protein Arginine Methyltransferase (PRMT) Inhibitors of Leukemia Cell ProliferationChen Wang, Hao Jiang, Jia Jin, et al.
Cancer Research|January 30, 2009
A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine designLisa M Ebert, Yu Chih Liu, Craig S Clements, et al.
Journal of Medicinal Chemistry|September 22, 2015
Discovery and Optimization of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Pharmacophore- and Docking-Based Virtual ScreeningFanwang Meng, Sufang Cheng, Hong Ding, et al.
Drug Design, Development and Therapy|December 16, 2020
Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β<sub>2</sub> Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) StudyShih-Lung Cheng, Ming-Lin Ho, Yun-Fa Lai, et al.
Communications Medicine|May 9, 2025
Outpatient acute kidney disease detection by national and institutional health dataHsiu-Yin Chiang, Hung-Chieh Yeh, Zi-Han Lin, et al.
Journal of Medicinal Chemistry|January 7, 2015
Fragment-based drug discovery of 2-thiazolidinones as BRD4 inhibitors: 2. Structure-based optimizationLele Zhao, Yingqing Wang, Danyan Cao, et al.
The Journal of Experimental Medicine|June 23, 2010
Allelic polymorphism in the T cell receptor and its impact on immune responsesStephanie Gras, Zhenjun Chen, John J Miles, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Journal of Chemical Information and Modeling|February 26, 2016
Identification of Novel Disruptor of Telomeric Silencing 1-like (DOT1L) Inhibitors through Structure-Based Virtual Screening and Biological AssaysShijie Chen, Linjuan Li, Yantao Chen, et al.
Chemmedchem|November 14, 2014
From ergolines to indoles: improved inhibitors of the human H3 receptor for the treatment of narcolepsyYves P Auberson, Thomas Troxler, Xuechun Zhang, et al.
Journal of Medicinal Chemistry|October 22, 2014
Identifying novel selective non-nucleoside DNA methyltransferase 1 inhibitors through docking-based virtual screeningShijie Chen, Yulan Wang, Wen Zhou, et al.
Journal of Medicinal Chemistry|October 12, 2017
Development of Potent Type I Protein Arginine Methyltransferase (PRMT) Inhibitors of Leukemia Cell ProliferationChen Wang, Hao Jiang, Jia Jin, et al.
Cancer Research|January 30, 2009
A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine designLisa M Ebert, Yu Chih Liu, Craig S Clements, et al.
Journal of Medicinal Chemistry|September 22, 2015
Discovery and Optimization of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Pharmacophore- and Docking-Based Virtual ScreeningFanwang Meng, Sufang Cheng, Hong Ding, et al.
Drug Design, Development and Therapy|December 16, 2020
Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β<sub>2</sub> Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) StudyShih-Lung Cheng, Ming-Lin Ho, Yun-Fa Lai, et al.
Communications Medicine|May 9, 2025
Outpatient acute kidney disease detection by national and institutional health dataHsiu-Yin Chiang, Hung-Chieh Yeh, Zi-Han Lin, et al.
Journal of Medicinal Chemistry|January 7, 2015
Fragment-based drug discovery of 2-thiazolidinones as BRD4 inhibitors: 2. Structure-based optimizationLele Zhao, Yingqing Wang, Danyan Cao, et al.
The Journal of Experimental Medicine|June 23, 2010
Allelic polymorphism in the T cell receptor and its impact on immune responsesStephanie Gras, Zhenjun Chen, John J Miles, et al.
Pageof 10